Global Liver Cancer Therapeutics Market Report and Forecast 2024-2032

Global Liver Cancer Therapeutics Market Outlook

The global liver cancer therapeutics market size attained a value of USD 2.50 billion in 2023, driven by the rising prevalence of liver cancer and the growing demand for effective treatment options across the globe. The market is anticipated to grow at a CAGR of 19.85% during the forecast period of 2024-2032 to reach a value of USD 12.78 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Liver Cancer Therapeutics Market Trends

Cancer is a life-threatening disease where the cells of a part of our body go out of control and starts growing rapidly. This disease, when effects and starts growing in the liver, is known as liver cancer or hepatic cancer. Although early signs of liver cancer are usually non-existent, they may include unconditional weight loss, appetite loss, upper abdominal pain, nausea, and vomiting, abdominal swelling, jaundice, general weakness and fatigue.

• The rising prevalence of liver cancer diseases is a major factor propelling market growth. People around the world are increasingly adopting a sedentary and unhealthy lifestyle, with increased consumption of alcohol and tobacco. These are very injurious for the liver and are the primary factor to aid liver cancer therapeutics market development.

• Market players are developing a sturdy drug pipeline that can aid cancer research and development. This will help in the development of new treatments with combination therapy that can provide enhanced treatment to the patients.

• Market players and institutions are increasingly engaging in research and development activities to develop novel medicines and improve the treatment of cancer through therapeutic drugs, which can extend the patients' lifespan. The availability of improved therapeutic options can significantly help in market expansion.

Global Liver Cancer Therapeutics Market Analysis

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on type, the market can be segmented into hepatocellular carcinoma, cholangio carcinoma, and hepatoblastoma, among others. Based on the therapy types, it can be bifurcated into ablation therapy, embolization therapy, radiation therapy, targeted therapy, immunotherapy, and chemotherapy. Based on the route of administration, the market for therapeutics includes oral and intravenous administration. 

Based on distribution channels, the market for cancer therapeutics can be segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The regional markets for the liver cancer therapeutics market can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. 

The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments and expansion plans. 

• Bayer AG

• Bristol-Myers Squibb Company

• Pfizer Inc.

• Exelixis, Inc.

• Merck & Co., Inc.

• Eli Lilly and Company

• F. Hoffmann-La Roche Ltd

• Others

Types of Therapies in the Market for Cancer Treatment

The market for liver cancer therapeutics, based on therapy types, can be divided into ablation therapy, embolization therapy, radiation therapy, targeted therapy, immunotherapy, and chemotherapy.

Among the various types of therapies, targeted therapy is expected to cover a major portion of the market owing to the increasing demand for targeted therapy due to its various advantages. Targeted therapies are utilised to directly target tumour cells while eliminating the chances of acquiring side effects on the surrounding normal cells. The increasing utilisation of targeted therapy can be a major driving factor for the segment and market value.

Various Routes of Administration for Liver Cancer Therapeutics

Based on the route of administration, the market can be divided into oral and intravenous administration. The intravenous route is the most widely by healthcare professionals as a method of administration for cancer therapy methods such as chemotherapy.

Healthcare professionals utilise this route of administration to administer multiple doses of medication or give medicated infusions. This route eliminates the need to inject a needle or tool multiple times to administer the same medicine and allows the medication to directly reach blood circulation.

Oral administration is growing in demand due to it being a non-invasive  method of administration. This mode of administration provides multiple benefits including patient comfort, cost-effectiveness, and easy large-scale manufacturing of the medication. The increasing patient preference for oral administration can prople market growth

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

Bayer AG, founded in 1863, and headquartered in Leverkusen, Germany, is a multinational pharmaceutical and biotechnology company. It is one of the world’s largest pharmaceutical companies with a speciality in various fields including pharmaceuticals, agricultural chemicals, seeds and biotechnology products, life sciences, and consumer health. The products developed by the company are applied to tackle some of the biggest challenges including global population growth, an ageing society, and to create sustainability.

Pfizer Inc. is an American pharmaceutical and biotechnology company. The company is headquartered in New York, United States, and it has been operating in the industry since 1849. The company works with an aim to introduce treatment solutions in the healthcare sector to create a healthier world. The company has expertise in utilising the science and global resources to improve healthcare around the world. The company is actively providing safe and effective medicines and healthcare services to underserved groups of people.

Bristol Myers Squibb Company is a multinational pharmaceutical company, headquartered in New York City, United States. The company was established in the year 1887 and has been operating in the field of biotechnology, pharmaceuticals, healthcare, and research and development, among others, to become one of the leading companies in the world.

The company has made multiple advancements in various medical fields such as oncology, haematology, immunology, and cardiovascular disease. Through their diverse array of products and innovative platforms, the company can assist patients in receiving better therapy at any stage of life.

Other market players include Exelixis, Inc., Merck & Co., Inc., Eli Lilly and Company, and F. Hoffmann-La Roche Ltd, among others.

Key Highlights of the Report

Liver Cancer Therapeutics Market Report Snapshots

Liver Cancer Therapeutics Market Size

Liver Cancer Therapeutics Market Trends

Liver Cancer Therapeutics Market Analysis

Liver Cancer Therapeutics Companies